套细胞淋巴瘤中CCND1和STAT3对SOX11表达的调控
本研究在多种人套细胞淋巴瘤(MCL)细胞系、原发肿瘤和患者来源异种移植瘤中,探讨细胞周期调控因子CCND1与信号转导及转录激活因子3(STAT3)对神经转录因子SOX11表达的调控机制。发现CCND1通过隔离组蛋白去乙酰化酶1和2(HDAC1/2)增加SOX11转录,而STAT3激活则下调SOX11表达;直接或间接靶向SOX11可诱导SOX11阳性MCL细胞毒性。
要点
- CCND1在MCL细胞系中异位表达增加SOX11转录,伴H3K9/14Ac升高。
- CCND1通过隔离HDAC1和HDAC2从SOX11位点导致SOX11上调。
- STAT3激活降低SOX11表达,靶向SOX11可诱导SOX11阳性MCL细胞毒性。
核心结论
- CCND1和STAT3参与调控SOX11表达,为MCL提供新见解和治疗意义。
研究设计与样本
- 研究在多种人MCL细胞系、原发肿瘤和患者来源异种移植瘤中开展机制实验。
主要发现
- CCND1在多种人MCL细胞系中异位表达导致SOX11转录增加,与乙酰化组蛋白H3K9和H3K14(H3K9/14Ac)增加相关。
- RNA干扰敲低HDAC1或HDAC2或用HDAC抑制剂伏立诺他抑制后,H3K9/14Ac和SOX11表达增加。
- CCND1与HDAC1和HDAC2相互作用并将其从SOX11位点隔离,导致SOX11上调。
- 磷酸化Y705 STAT3与SOX11表达在MCL细胞系、原发肿瘤和患者来源异种移植瘤中呈潜在负相关。
- 抑制上游JAK1或JAK2或敲低STAT3增加SOX11表达,而IL-21诱导的STAT3激活或过表达组成性激活STAT3降低SOX11表达。
临床怎么用
- 作者指出CCND1和STAT3参与调控SOX11表达,为MCL提供新见解和治疗意义。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The neural transcription factor SOX11 is usually highly expressed in typical mantle cell lymphoma (MCL), but it is absent in the more indolent form of MCL. Despite being an important diagnostic marker for this hard-to-treat malignancy, the mechanisms of aberrant SOX11 expression are largely unknown. Herein, we describe 2 modes of SOX11 regulation by the cell-cycle regulator cyclin D1 (CCND1) and the signal transducer and activator of transcription 3 (STAT3). We found that ectopic expression of CCND1 in multiple human MCL cell lines resulted in increased SOX11 transcription, which correlated with increased acetylated histones H3K9 and H3K14 (H3K9/14Ac). Increased H3K9/14Ac and SOX11 expression was also observed after histone deacetylase 1 (HDAC1) or HDAC2 was depleted by RNA interference or inhibited by the HDAC inhibitor vorinostat. Mechanistically, we showed that CCND1 interacted with and sequestered HDAC1 and HDAC2 from the SOX11 locus, leading to SOX11 upregulation. Interestingly, our data revealed a potential inverse relationship between phosphorylated Y705 STAT3 and SOX11 expression in MCL cell lines, primary tumors, and patient-derived xenografts. Functionally, inactivation of STAT3 by inhibiting the upstream Janus kinase (JAK) 1 or JAK2 or by STAT3 knockdown was found to increase SOX11 expression, whereas interleukin-21 (IL-21)-induced STAT3 activation or overexpression of the constitutively active form of STAT3 decreased SOX11 expression. In addition, targeting SOX11 directly by RNA interference or indirectly by IL-21 treatment induced toxicity in SOX11+ MCL cells. Collectively, we demonstrate the involvement of CCND1 and STAT3 in the regulation of SOX11 expression, providing new insights and therapeutic implications in MCL.
引用
- Mohanty A, Sandoval N, Phan A, et al. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Blood. 2018. PMID: 30530749. doi:10.1182/blood-2018-05-851667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。